INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaJérôme Fayette, Helena Rebelo‐de‐Andrade, Danny Rischin et al.|Clinical Cancer Research|2025Cited by 26
The 1918–1919 Influenza Pandemic in Portugal: A Regional Analysis of Death ImpactBaltazar Nunes, Helena Rebelo‐de‐Andrade, Susana Pereira Silva et al.|American Journal of Epidemiology|2018Cited by 22
COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severitySusana David, Helena Rebelo‐de‐Andrade|Immunogenetics|2022Cited by 12
Supplementary Data 1 from INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaJérôme Fayette, Jan Paul de Boer, Lisa Licitra et al.|Unknown|2025Cited by 0